Facebook
Twitter
Telegram
Report an ErrorINmune Bio Financial Statements 2011-2024 | INMB
Annual Financial Statements INmune Bio
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
211 M | 166 M | 163 M | 236 M | 49.1 M | - | - | - | - | - | - | - | - |
Shares |
18 M | 17.9 M | 16.1 M | 12.9 M | 10.3 M | - | - | - | - | - | - | - | - |
Historical Prices |
11.8 | 9.25 | 10.1 | 18.2 | 4.93 | - | - | - | - | - | - | - | - |
Net Income |
-30 M | -27.3 M | -30.3 M | -12.1 M | -7.68 M | -12.4 M | -831 K | -277 K | - | - | - | - | - |
Revenue |
155 K | 374 K | 181 K | 10.9 K | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | -10.9 K | - | - | - | - | - | - | - | - | - |
Operating Income |
-29.7 M | -26 M | -29.2 M | -12.2 M | -7.76 M | -12.4 M | -981 K | - | - | - | - | - | - |
Interest Expense |
2.28 M | 2.01 M | - | 129 K | 77.7 K | - | 150 K | - | - | - | - | - | - |
EBITDA |
-29.7 M | -26 M | -29.2 M | -12.2 M | -10.8 M | -12.4 M | -1.13 M | -177 K | - | - | - | - | - |
Operating Expenses |
29.9 M | 26.3 M | 29.3 M | 12.2 M | 9.3 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
9.62 M | 9.26 M | 8.79 M | 6.32 M | 6.02 M | 11.3 M | 546 K | 126 K | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement INmune Bio
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
18 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 17.8 M | 17.3 M | 15 M | 14.3 M | 13.5 M | 12.9 M | 10.8 M | 10.7 M | 10.8 M | 10.8 M | 10.2 M | 9.39 M | 8.72 M | 8.72 M | 8.72 M | 8.55 M | 8.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-8.56 M | -6.5 M | -6.54 M | - | -7.72 M | -6.84 M | -6.9 M | - | -9.46 M | -6.66 M | -4.56 M | - | -4.72 M | -2.11 M | -2.07 M | - | -3.07 M | -392 K | -1.9 M | - | -1.54 M | -6.17 M | -2.85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
43 K | 46 K | 38 K | - | 98 K | 16 K | 163 K | - | 14 K | - | 4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-8.53 M | -6.41 M | -6.42 M | - | -7.44 M | -6.39 M | -6.48 M | - | -9.02 M | -6.55 M | -4.55 M | - | -4.82 M | -2.11 M | -2.09 M | - | -3.08 M | -428 K | -1.91 M | - | -1.54 M | -6.17 M | -2.85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | -8 K | - | 102 K | -395 | 22 K | - | 17.2 K | 36.3 K | 10 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-8.53 M | -6.41 M | -6.42 M | - | -7.44 M | -6.39 M | -6.48 M | - | -9.02 M | -6.55 M | -4.55 M | - | -4.82 M | -2.11 M | -2.09 M | - | -3.08 M | -428 K | -1.91 M | - | -1.54 M | -6.17 M | -2.85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
8.57 M | 6.46 M | 6.46 M | - | 7.54 M | 6.4 M | 6.64 M | - | 9.04 M | 6.55 M | 4.55 M | - | 4.82 M | 2.11 M | 2.09 M | - | 3.08 M | 428 K | 1.91 M | - | 1.54 M | 6.17 M | 2.85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.59 M | 2.31 M | 2.33 M | - | 2.38 M | 2.22 M | 2.33 M | - | 2.52 M | 2.09 M | 2.06 M | - | 2.46 M | 357 K | 1.3 M | - | 1.92 M | 1.34 M | 1.3 M | - | 885 K | 5.89 M | 2.74 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency